ERNEST BRANDT: Open Payments
NPI 1235523234 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,594 in 200 payments from 22 companies in 2025. Trend: 2023 $4,822 · 2024 $4,653 · 2025 $5,594
Food & beverage: $4,761Travel & lodging: $833
| Company | Payments | Amount |
|---|---|---|
| CVRx, Inc. | 8 | $1,203 |
| AstraZeneca Pharmaceuticals LP | 18 | $493 |
| Novartis Pharmaceuticals Corporation | 33 | $491 |
| Alnylam Pharmaceuticals Inc. | 20 | $462 |
| E.R. Squibb & Sons, L.L.C. | 17 | $351 |
| Novo Nordisk Inc | 9 | $340 |
| Kestra Medical Technology Services, Inc. | 14 | $321 |
| Abbott Laboratories | 6 | $287 |
| PFIZER INC. | 11 | $215 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 14 | $213 |
Products named: Barostim Neo System, LEQVIO, AMVUTTRA, WAINUA, Assure WCD, Ozempic, JARDIANCE, THORATEC HEARTMATE 3 LVAS IMPLANT KIT.
Industry payments across TN — which companies pay providers there.
